| Next 10 |
Ad
ANNX News and Press Annexon Inc.
News | Annexon Inc. (NASDAQ:ANNX)
-
2024-10-01 08:20:07 ET With Q3 now in the rearview mirror, Wells Fargo came out on Tuesday and spotlighted ten stocks that fall inside its “Q4 ’24 tactical ideas list,” which are companies it views have the potential to see significant quarterly catalysts that could dri...
-
2024-09-24 23:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity ARCHER II Phase 3 Pivotal Program in GA Underway with Data Expected Second Half 2026 ...
-
BRISBANE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain, and eye, today announced the strengthening of its senior leadership team with the appointment ...
-
BRISBANE, Calif., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain and eye, today announced that Douglas Love, Esq., president & chief executive officer, will part...
-
2024-08-17 09:28:11 ET Summary Annexon’s ANX005 shows promise for GBS. Phase 3 trial results indicate expedited recovery and durable benefits. ANNX targets the classical complement pathway, specifically the C1q protein, to address autoimmune, neurodegenerative, and ophthalm...
-
2024-08-12 17:27:13 ET More on Annexon Biosciences Annexon: Complement Inhibition Of GBS Only The Beginning With Strong Tech In Place Annexon spikes after updating late-stage results for lead asset against GBS Biggest stock movers today: BBWI, GME, HQY, and more ...
-
2024-08-12 08:34:34 ET More on Annexon Biosciences Annexon: Complement Inhibition Of GBS Only The Beginning With Strong Tech In Place Annexon spikes after updating late-stage results for lead asset against GBS Biggest stock movers today: BBWI, GME, HQY, and more ...
-
Single, Well-Tolerated Infusion of ANX005 Significantly Accelerated Recovery of GBS Patients vs. Placebo in Pivotal Phase 3 Trial; Potential to be First Targeted Therapy for GBS; Topline Real-World Evidence (RWE) Comparability Data Now Expected by Year-End 2024 Dosing Initiated in ARCHER ...
-
Chicken Soup for the Soul Entertainment Inc. (CSSEQ) is expected to report for Q2 2024 Amplitech Group Inc. (AMPG) is expected to report for Q2 2024 Adaptimmune Therapeutics plc (ADAP) is expected to report $0 for Q2 2024 Augmedix Inc. (AUGX) is expected to report $-0.12 for Q2 2024 ...
Stock Information
Get ANNX Alerts
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-09-24 23:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
-
Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity ARCHER II Phase 3 Pivotal Program in GA Underway with Data Expected Second Half 2026 ...
-
BRISBANE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain, and eye, today announced the strengthening of its senior leadership team with the appointment ...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...